Warren Buffett's huge losses on Teva mount - Globes
December 10th Options Now Available For Teva Pharmaceutical Industries | Nasdaq
From left, Dan S. Suesskind, CFO, Shlomo Yanai, incoming president and CEO, Israel Makov, outgoing president and CEO, and Eli Hurvitz, chairman of the board of Teva Pharmaceutical Industries, Ltd. take part
teva-stock-nasdaq-risk-assessment | The World of English
Shlomo Yanai, incoming president and CEO (L), and Israel Makov, outgoing president and CEO of Teva Pharmaceutical Industries, Ltd. take part in the opening bell ceremonies at the NASDAQ in New York